Lexicon Pharmaceuticals Pfizer: Which Stock Is Best Buy 2026
In 2026, investors face a choice between a nimble biotech player and a global pharma titan. This guide compares Lexic...
Staking stablecoins can offer rewards, but there are risks to consider. This intro highlights potential issues and basic protections for stakers.
27,764 articlesIn 2026, investors face a choice between a nimble biotech player and a global pharma titan. This guide compares Lexic...
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Investors weigh SpaceX’s long-term potential as AI-driven data services and satellite connectivity could unlock a mul...
Strive's CEO says recent STRC and SATA declines were driven by leverage-induced liquidations rather than weakening fu...
Nscale raised billions to power Europe’s AI ambitions, but the company now confronts the need to prove it can transla...
Five years after investing in KWEB, the math reveals a hard lesson about concentration, fee drag, and the complexity ...
A growing number of retirees moved cash into Treasury bills to lock in near-4% yields. But the tax system on Social S...
Metaplanet announces a major move to transform its Bitcoin treasury into regulated income through a securities distri...
A heat dome is targeting the U.S. this July 4 weekend, pushing temperatures into the 90s and 100s in many cities. Exp...
In 2026, one AI-focused stock has become the darling of bulls and analysts alike. This article dives into the reasons...
As rate conditions shift, two ultra-short Treasury ETFs, SGOV and BIL, vie for cash allocations. This analysis weighs...
From repeated loan denials to a growing 10+ unit multifamily portfolio, this deal diary-style story reveals the strat...